Get started
Author

Selma Ahcene Djaballah

Observed names: Ahcene-Djaballah, Selma, S Ahcene-Djaballah, S. Ahcene Djaballah, S. Ahcene-Djaballah, S., AhceneDjaballah, Selma Ahcene-Djaballah
ORCID: 0000-0002-3878-3595
Observed ORCID: 0000-0002-3878-3595
OpenAlex ID: A5080249249
HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target
2022 · Selma Ahcene Djaballah, Francesca Daniel, et al. · American Society of Clinical Oncology Educational Book · 95
Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives
2019 · Antonio Pellino, Erika Riello, et al. · World Journal of Gastroenterology · 94
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population
2024 · Margherita Rimini, Lorenzo Fornaro, et al. · European Journal of Cancer · 59
The impact of panitumumab treatment on survival and quality of life in patients with RAS wild-type metastatic colorectal cancer
2019 · Francesca Battaglin, Alberto Puccini, et al. · Cancer Management and Research · 34
PDF
A retrospective study on the incidence of medication-related osteonecrosis of the jaws (MRONJ) associated with different preventive dental care modalities
2021 · Christian Bacci, Alessia Cerrato, et al. · Supportive Care in Cancer · 30
PDF
Prevalence of pain in patients with cancer aged 70 years or older: A prospective observational study
2019 · Antonella Brunello, Selma Ahcene-Djaballah, et al. · Journal of Geriatric Oncology · 20
A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC ‐D Index
2025 · Mara Persano, Margherita Rimini, et al. · Liver International · 11
PDF
Ramucirumab: the long and winding road toward being an option for mCRC treatment
2019 · Celine Debeuckelaere, Sabina Murgioni, et al. · Expert Opinion on Biological Therapy · 11
Predictive markers in elderly patients with estrogen receptor-positive breast cancer treated with aromatase inhibitors: an array-based pharmacogenetic study
2015 · E Rumiato, A Brunello, et al. · The Pharmacogenomics Journal · 11
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population
2024 · Federica Lo Prinzi, Francesca Salani, et al. · The Oncologist · 10
PDF
Management and Outcomes of Older Patients (Age ≥ 70 Years) with Advanced Soft Tissue Sarcoma and Role of Geriatric Assessment and Oncological Multidimensional Prognostic Index (Onco-MPI) in a Real-World Setting
2023 · Benedetta Chiusole, Ilaria Tortorelli, et al. · Cancers · 8
PDF
ctDNA as promising tool for the assessment of minimal residual disease (MRD) and the need of an adjuvant treatment in gastroesophageal adenocarcinoma
2022 · Vittoria Matilde Piva, Maria Caterina De Grandis, et al. · Updates in Surgery · 7
Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real‐life worldwide population
2025 · Federica Lo Prinzi, Francesca Salani, et al. · International Journal of Cancer · 6
The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population
2025 · Margherita Rimini, Lorenzo Fornaro, et al. · JNCI Journal of the National Cancer Institute · 6
PDF
Choriocarcinoma: Diagnosis, treatment and management of a rare germ cell tumour. An update review
2026 · Francesco Pierantoni, Fabiana Caliciotti, et al. · Tumori Journal · 4
PDF
Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer
2025 · Florian Castet, Carles Fabregat-Franco, et al. · Journal of Hepatology · 4
Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real‐world results from a multicenter and multinational study
2025 · Margherita Rimini, Lorenzo Fornaro, et al. · International Journal of Cancer · 4
PDF
Hypertransaminasemia in Metastatic Renal Cell Carcinoma Patients Receiving Immune-Based Combinations: A Meta-Analysis
2023 · Alessandro Rizzo, Giacomo Nuvola, et al. · Immunotherapy · 3
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal malignancies: a monocentric, single-arm open-label phase II clinical trial
2025 · Marco Tonello, Carola Cenzi, et al. · Surgical Oncology · 2
Impact of Antibiotic Therapy in Patients with Cholangiocarcinoma Treated with Chemoimmunotherapy
2025 · Francesco Vitiello, Caterina Vivaldi, et al. · Oncology · 2
Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab
2026 · Silvia Camera, Lorenzo Fornaro, et al. · Targeted Oncology · 1
Sex differences in toxicity and outcomes in patients with sarcoma treated in the perioperative setting at a comprehensive cancer center
2025 · Ilaria Tortorelli, Benedetta Chiusole, et al. · Frontiers in Oncology · 1
PDF
P-275 FOLFOX versus FOLFIRI as second-line treatment after cisplatin-gemcitabine in patients with advanced biliary tract cancers
2023 · F. Nichetti, M. Rizzato, et al. · Annals of Oncology · 1
PDF
1517P Role of geriatric assessment and oncological multidimensional prognostic index (onco-MPI) in older patients (age ≥70 years) with advanced soft tissue sarcoma in a real-world setting
2022 · B. Chiusole, I. Tortorelli, et al. · Annals of Oncology · 1
Medication-related osteonecrosis of the jaw in patients with bone metastases from solid tumors: analysis of the Istituto Oncologico Veneto case series
2021 · Selma Ahcene-Djaballah, Stefania Zovato, et al. · 1
PDF
Works count: 39
Citation count: 426
H-index: 10
I10-index: 10
Year
Topic
Type